Search

everythinglearnresearchcommunity

for

Search:↓

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Vitamin A toxicity likely caused the patient's high calcium levels.

Both lasers are equally effective and safe for treating freckles.

Finasteride effectively reduces symptoms of enlarged prostate with minimal side effects.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

Metformin may lower PSA levels, possibly affecting prostate cancer development.

CT scans can find serious prostate cancer even when PSA levels are low.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Hair loss can be an early sign of prostate enlargement.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Long-term diabetes is linked to lower prostate cancer risk.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Finasteride improves chronic pelvic pain, saw palmetto doesn't.

Lovastatin doesn't improve lower urinary tract symptoms treatment.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.